Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Watanabe, Y., Nagai, F., Morotomi, M., Sakon, H., & Tanaka, R. (2010). Bacteroides clarus sp. nov., Bacteroides fluxus sp. nov. and Bacteroides oleiciplenus sp. nov., isolated from human faeces. International Journal of Systematic and Evolutionary Microbiology, 60(Pt 8), 1864–1869.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (CCUG, Alkhalil2017)
DNA G+C(%): 45.3
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
Acetate, Succinate |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: R(8)
oxacillin: R(32)
piperacillin: Var(MIC50): 7), MIC90: Var(7
meropenem: S(0.19)
|
cefotaxime: Var(MIC50): 16), MIC90: Var(16
cefoxitin: Var(MIC50): 8), MIC90: Var(8
ceftazidime: R(32)
|
tobramycin: R(>1024)
|
azithromycin: S(1.5)
erythromycin: S(1.5)
clarithromycin: S(0.125)
spiramycin: S(0.75)
|
ciprofloxacin: Var(MIC50): 16), MIC90: Var(16
gatifloxacin: S(0.5)
moxifloxacin: S(1.5)
norfloxacin: R(>256)
ofloxacin: Var(MIC50): 6), MIC90: Var(6
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(0.032)
tigecycline: S(0.032)
|
|
|
metronidazole: S(1)
sulfamethoxazole: R(96)
|
|